Wenge Zhu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Signaling Pathway

Dna Damage Response

Metastatic Breast Cancer

Top Venues

Nature communications

Clinical and translational medicine

Research square

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Zhang, Shuyan Zhou, Yan Kai, Ya-Qin Zhang, Changmin Peng, Zhuqing Li, Muhammad Jameel Mughal, Belmar Julie, Xiaoyan Zheng, Junfeng Ma, Cynthia X Ma, Min Shen, Matthew D Hall, Shunqiang Li, Wenge Zhu
O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer. Nature communications 15 (1) (2024)
Yi Zhang, Shuyan Zhou, Yan Kai, Ya-Qin Zhang, Changmin Peng, Zhuqing Li, Muhammad Jameel Mughal, Belmar Julie, Xiaoyan Zheng, Junfeng Ma, Cynthia X Ma, Min Shen, Matthew D Hall, Shunqiang Li, Wenge Zhu
O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer. Nature communications 15 (1) (2024)
Yi Zhang, Shuyan Zhou, Yan Kai, Ya-Qin Zhang, Changmin Peng, Zhuqing Li, Muhammad Jameel Mughal, Belmar Julie, Xiaoyan Zheng, Junfeng Ma, Cynthia X Ma, Min Shen, Matthew D Hall, Shunqiang Li, Wenge Zhu
O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer. Nature communications 15 (1) (2024)
Yi Zhang, Shuyan Zhou, Yan Kai, Ya-Qin Zhang, Changmin Peng, Zhuqing Li, Muhammad Jameel Mughal, Belmar Julie, Xiaoyan Zheng, Junfeng Ma, Cynthia X Ma, Min Shen, Matthew D Hall, Shunqiang Li, Wenge Zhu
O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer. Nature communications 15 (1) (2024)
Yi Zhang, Shuyan Zhou, Yan Kai, Ya-Qin Zhang, Changmin Peng, Zhuqing Li, Muhammad Jameel Mughal, Belmar Julie, Xiaoyan Zheng, Junfeng Ma, Cynthia X Ma, Min Shen, Matthew D Hall, Shunqiang Li, Wenge Zhu
O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer. Nature communications 15 (1) (2024)
Wenge Zhu, Y I Zhang, Shuyan Zhou, Yan Kai, Ya-Qin Zhang, Changmin Peng, Zhuqing Li, Muhammad Mughal, Junfeng Ma, Shunqiang Li, Cynthia X Ma, Min Shen, Matthew D Hall
O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer. Research square (2023)
Yuan Zhou, Yi Zhang, Changmin Peng, Zhuqing Li, Huadong Pei, Haiping Pei, Wenge Zhu
And-1 O-GlcNAcylation regulates homologous recombination repair and radioresistance in colorectal cancer. Clinical and translational medicine 12 (4) (2022)
Yi Zhang, Jing Li, Yuan Zhou, Zhuqing Li, Changmin Peng, Huadong Pei, Wenge Zhu
And-1 Coordinates with the FANCM Complex to Regulate Fanconi Anemia Signaling and Cisplatin Resistance. Cancer research 82 (18) (2022)
Jing Li, Yi Zhang, Jing Sun, Leyuan Chen, Wenfeng Gou, Chi-Wei Chen, Yuan Zhou, Zhuqing Li, David W Chan, Ruili Huang, Huadong Pei, Wei Zheng, Yiliang Li, Menghang Xia, Wenge Zhu
Discovery and characterization of potent And-1 inhibitors for cancer treatment. Clinical and translational medicine 11 (12) (2022)
Yi Zhang, Huiqiang Wei, Yuan Zhou, Zhuqing Li, Wenfeng Gou, Yunxiao Meng, Wei Zheng, Jing Li, Yiliang Li, Wenge Zhu
Identification of potent SENP1 inhibitors that inactivate SENP1/JAK2/STAT signaling pathway and overcome platinum drug resistance in ovarian cancer. Clinical and translational medicine 11 (12) (2022)
Jing Li, Ruiqin Wu, Mingo M H Yung, Jing Sun, Zhuqing Li, Hai Yang, Yi Zhang, Stephanie S Liu, Annie N Y Cheung, Hextan Y S Ngan, John C Braisted, Wei Zheng, Huiqiang Wei, Yingtang Gao, Peter Nemes, Huadong Pei, David W Chan, Yiliang Li, Wenge Zhu
SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance. Cell death & disease 12 (4) (2021)